Asthma
Please log in or register to continue reading.
แนวทางการจ่ายยา dupilumab ในรักษาโรคหืดรุนแรง
Nearly 1 in 3 patients with uncontrolled moderate‑to‑severe type 2 asthma achieved clinical remission with dupilumab. Our latest update highlights key QUEST/TRAVERSE data, remission criteria, and implications for practice.
Review the clinical impact of mucus plugging in asthma and available evidence on changes in mucus score, mucus volume, and lung function observed in clinical studies of dupilumab.
Please log in or register to continue reading.
The account is under identity verification process and it will be completed within 48 hours upon your registration. At the end you will receive a confirmation email and you will be able to access the area dedicated to you.
Please check you email for verification emali.
You do not have the correct verified role to view this content.
Welcome to Sanofi Campus for Health Care Professionals.
Please check your inbox and validate your email address to confirm your account.
You can access personalized content, communications, events and resources for healthcare professionals. In addition, you can update your preferences from your account page at any time.